RCAT vs NPK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

RCAT

60.4
AI Score
VS
RCAT Wins

NPK

58.6
AI Score

Investment Advisor Scores

RCAT

60score
Recommendation
BUY

NPK

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric RCAT NPK Winner
Revenue 35.66M 265.25M NPK
Net Income -61.81M 22.49M NPK
Gross Margin 14.7% 17.4% NPK
Net Margin -173.3% 8.5% NPK
Operating Income -65.95M 27.45M NPK
ROE -13.1% 5.5% NPK
ROA -11.7% 4.5% NPK
Total Assets 527.49M 498.61M RCAT
Cash 325.55M 15.79M RCAT
Current Ratio 14.86 5.22 RCAT

Relative Price Performance (Last 90 Days)

RCAT 1M: -15.4% · 3M: -57.1% NPK 1M: -1.5% · 3M: +4.9%

Current Technical Phase

RCAT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -25.4%), weak momentum, RSI 43

RSI (14): 42.7 · Price: $4.39

NPK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.4 · Price: $144.55

Fundamentals Snapshot

Metric RCAT NPK
Market Cap — —
Forward P/E -14.0 20.2
Trailing P/E — 24.5
Revenue (TTM) — —
Revenue Growth 5.3% 0.2%
Gross Margin 0.1% 0.2%
Operating Margin -1.9% 0.1%
EPS -0.89 5.98
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, RCAT is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.